Valo Therapeutics Italy
Healthcare
HQ: Milan, Italy
Investors: 1
Develops antigen-coated oncolytic viruses for cancer immunotherapy
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Cdp Venture Capital | Current | - | - | Website |
Develops antigen-coated oncolytic viruses for cancer immunotherapy
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Cdp Venture Capital | Current | - | - | Website |